Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients

Combination antidepressant therapy for major depressive disorder: Speed and probability of remission

(2013) Jonathan W. Stewart et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Systematic Review of Blinding Assessment in Randomized Controlled Trials in Schizophrenia and Affective Disorders 2000-2010

(2013) Christopher Baethge et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

Antidepressant Combinations: Cutting Edge Psychopharmacology or Passing Fad?

(2013) Michael E. Thase   Current Psychiatry Reports

Efficacy and safety of add on low-dose mirtazapine in depression

(2012) DineshK Badyal et al.   INDIAN JOURNAL OF PHARMACOLOGY

Antidepressant monotherapy compared with combinations of antidepressants in the treatment of resistant depressive patients: A randomized, open-label study

(2012) Martin Bares et al.   INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE

Antidepressant combination for major depression in incomplete responders—a systematic review

(2012) Fábio Lopes Rocha et al.   JOURNAL OF AFFECTIVE DISORDERS

Combination of Antidepressants in the Treatment of Major Depressive Disorder

(2012) Fábio Lopes Rocha et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Christopher J L Murray et al.   LANCET

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

(2011) A. John Rush et al.   AMERICAN JOURNAL OF PSYCHIATRY

Bupropion as an Augmenting Agent in Patients of Depression with Partial Response

(2011) Gaurav Gulrez et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

The size and burden of mental disorders and other disorders of the brain in Europe 2010

(2011) H.U. Wittchen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects

(2011) Tiago V. Pereira et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Comparisons of the Efficacy and Tolerability of Extended-Release Venlafaxine, Mirtazapine, and Paroxetine in Treatment-Resistant Depression

(2010) Yiru Fang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy

(2009) T. Bschor et al.   ACTA PSYCHIATRICA SCANDINAVICA

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study

(2009) Pierre Blier et al.   AMERICAN JOURNAL OF PSYCHIATRY

Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation

(2009) Pierre Blier et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Therapy-resistant depression

(2009) Tom Bschor   Expert Review of Neurotherapeutics

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.

(2009) Raymond W. Lam et al.   JOURNAL OF AFFECTIVE DISORDERS

Pharmacokinetics and Efficacy of Fluvoxamine and Amitriptyline in Depression

(2009) Sandra Vezmar et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder

(2009) Andrew F. Leuchter et al.   PSYCHIATRY RESEARCH

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study

(2009) Andrew F. Leuchter et al.   PSYCHIATRY RESEARCH

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

(2008) Erick H. Turner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reasons or excuses for avoiding meta-analysis in forest plots

(2008) John P A Ioannidis et al.   BMJ-British Medical Journal